525 related articles for article (PubMed ID: 27859689)
1. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
[TBL] [Abstract][Full Text] [Related]
2. Protective immunity against Chlamydia trachomatis genital infection induced by a vaccine based on the major outer membrane multi-epitope human papillomavirus major capsid protein L1.
Xu W; Liu J; Gong W; Chen J; Zhu S; Zhang L
Vaccine; 2011 Mar; 29(15):2672-8. PubMed ID: 21324344
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunization with recombinant MOMP genetically linked with modified cholera toxin confers protection against Chlamydia trachomatis infection.
Singh SR; Hulett K; Pillai SR; Dennis VA; Oh MK; Scissum-Gunn K
Vaccine; 2006 Feb; 24(8):1213-24. PubMed ID: 16194585
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus surface antigen as delivery vector can enhance Chlamydia trachomatis MOMP multi-epitope immune response in mice.
Zhu S; Feng Y; Rao P; Xue X; Chen S; Li W; Zhu G; Zhang L
Appl Microbiol Biotechnol; 2014 May; 98(9):4107-17. PubMed ID: 24458565
[TBL] [Abstract][Full Text] [Related]
5. DNA plasmid vaccine carrying Chlamydia trachomatis (Ct) major outer membrane and human papillomavirus 16L2 proteins for anti-Ct infection.
Wang L; Cai Y; Xiong Y; Du W; Cen D; Zhang C; Song Y; Zhu S; Xue X; Zhang L
Oncotarget; 2017 May; 8(20):33241-33251. PubMed ID: 28402260
[TBL] [Abstract][Full Text] [Related]
6. Recombinant expression of Chlamydia trachomatis major outer membrane protein in E. Coli outer membrane as a substrate for vaccine research.
Wen Z; Boddicker MA; Kaufhold RM; Khandelwal P; Durr E; Qiu P; Lucas BJ; Nahas DD; Cook JC; Touch S; Skinner JM; Espeseth AS; Przysiecki CT; Zhang L
BMC Microbiol; 2016 Jul; 16(1):165. PubMed ID: 27464881
[TBL] [Abstract][Full Text] [Related]
7. Comparison of immune responses and protective efficacy of intranasal prime-boost immunization regimens using adenovirus-based and CpG/HH2 adjuvanted-subunit vaccines against genital Chlamydia muridarum infection.
Brown TH; David J; Acosta-Ramirez E; Moore JM; Lee S; Zhong G; Hancock RE; Xing Z; Halperin SA; Wang J
Vaccine; 2012 Jan; 30(2):350-60. PubMed ID: 22075089
[TBL] [Abstract][Full Text] [Related]
8. Immunization with the Chlamydia trachomatis major outer membrane protein, using the outer surface protein A of Borrelia burgdorferi as an adjuvant, can induce protection against a chlamydial genital challenge.
Pal S; Luke CJ; Barbour AG; Peterson EM; de la Maza LM
Vaccine; 2003 Mar; 21(13-14):1455-65. PubMed ID: 12615442
[TBL] [Abstract][Full Text] [Related]
9. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes.
Igietseme JU; Murdin A
Infect Immun; 2000 Dec; 68(12):6798-806. PubMed ID: 11083798
[TBL] [Abstract][Full Text] [Related]
10. Phosphate substitution in an AlOOH - TLR4 adjuvant system (SPA08) modulates the immunogenicity of Serovar E MOMP from Chlamydia trachomatis.
Visan L; Sanchez V; Kania M; de Montfort A; de la Maza LM; Ausar SF
Hum Vaccin Immunother; 2016 Sep; 12(9):2341-50. PubMed ID: 27104338
[TBL] [Abstract][Full Text] [Related]
11. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection.
Su H; Parnell M; Caldwell HD
Vaccine; 1995 Aug; 13(11):1023-32. PubMed ID: 8525685
[TBL] [Abstract][Full Text] [Related]
12. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge.
Pal S; Theodor I; Peterson EM; de la Maza LM
Infect Immun; 1997 Aug; 65(8):3361-9. PubMed ID: 9234798
[TBL] [Abstract][Full Text] [Related]
13. Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.
Murthy AK; Chambers JP; Meier PA; Zhong G; Arulanandam BP
Infect Immun; 2007 Feb; 75(2):666-76. PubMed ID: 17118987
[TBL] [Abstract][Full Text] [Related]
14. Protection against an intranasal challenge by vaccines formulated with native and recombinant preparations of the Chlamydia trachomatis major outer membrane protein.
Sun G; Pal S; Weiland J; Peterson EM; de la Maza LM
Vaccine; 2009 Aug; 27(36):5020-5. PubMed ID: 19446590
[TBL] [Abstract][Full Text] [Related]
15. Route of Vaccine Administration Influences the Impact of Fms-Like Tyrosine Kinase 3 Ligand (Flt3L) on Chlamydial-Specific Protective Immune Responses.
Pais R; Omosun Y; Igietseme JU; Fujihashi K; Eko FO
Front Immunol; 2019; 10():1577. PubMed ID: 31333682
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity and protection against genital Chlamydia infection and its complications by a multisubunit candidate vaccine.
Ifere GO; He Q; Igietseme JU; Ananaba GA; Lyn D; Lubitz W; Kellar KL; Black CM; Eko FO
J Microbiol Immunol Infect; 2007 Jun; 40(3):188-200. PubMed ID: 17639158
[TBL] [Abstract][Full Text] [Related]
17. Transcutaneous immunization with a novel lipid-based adjuvant protects against Chlamydia genital and respiratory infections.
Hickey DK; Aldwell FE; Beagley KW
Vaccine; 2009 Oct; 27(44):6217-25. PubMed ID: 19698810
[TBL] [Abstract][Full Text] [Related]
18. A multi-epitope vaccine based on Chlamydia trachomatis major outer membrane protein induces specific immunity in mice.
Tu J; Hou B; Wang B; Lin X; Gong W; Dong H; Zhu S; Chen S; Xue X; Zhao KN; Zhang L
Acta Biochim Biophys Sin (Shanghai); 2014 May; 46(5):401-8. PubMed ID: 24681882
[TBL] [Abstract][Full Text] [Related]
19. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge.
Pal S; Davis HL; Peterson EM; de la Maza LM
Infect Immun; 2002 Sep; 70(9):4812-7. PubMed ID: 12183524
[TBL] [Abstract][Full Text] [Related]
20. Recombinant Vibrio cholerae ghosts as a delivery vehicle for vaccinating against Chlamydia trachomatis.
Eko FO; Lubitz W; McMillan L; Ramey K; Moore TT; Ananaba GA; Lyn D; Black CM; Igietseme JU
Vaccine; 2003 Apr; 21(15):1694-703. PubMed ID: 12639492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
